Therma Bright Inc V.THRM

NR

[Smokey1958]

The most important part of the NR is the last paragraph. Management has set a new baseline with options now set at $.08. Imho there was no need to include this in this NR if it wasn't currently relevant.

[spygate]

why is that important? In June 2022 they did this 'The options are exercisable for a period of three years at a price of $0.25 per share.  And we never got there so there is no guarantee we will get to 8 cents again either.

[Smokey1958]

What are you talking about? When those options were promoted in 2022 THRM, although they should have been, was not at the same stage it is now. Something definitely went sideways with AcuVid for which we will never get the story. Venowave alone presents a very different scenario for 2024, 2025 and beyond. For one, the device has already cleared all the major issues and was thoroughly tested ...in

[spygate]

I hope you are right...and I beleive we are in a better business space now with a legitimate product suite but I was coomenting on the fact that just because a company prices options at a certain price does not gurantee we stay or get to that price within the timelines...its been proven time and time again and to say otherwise is not true